Impact of Changing Physician Compensation for Actinic Keratosis Treatment on Patients’ Access to Care

Abstract

Keywords

actinic keratosis cryotherapy dermatology health services research universal health care

Get full access to this article

View all access options for this article.

References

Landis

ET.

Davis

SA.

Taheri

Feldman

. Top dermatologic diagnoses by age. Dermatol Online J. 2014;20(4):22368. doi:10.5070/D3204022368

24746305

Foote

JA.

Harris

RB.

Giuliano

et al. Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults. Int J Cancer. 2001;95(1):7-11.doi:10.1002/1097-0215(20010120)95:1<7::AID-IJC1001>3.0.CO;2-X

11241303

Noels

EC.

Hollestein

LM.

van Egmond

et al. Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis. Br J Dermatol. 2019;181(3):544-553.doi:10.1111/bjd.17632

30636037

Statistics Canada . Table 17-10-0009-01 Population estimates, quarterly. Accessed June 16, 2020. https://doi.org/10.25318/1710000901-eng

Flohil

SC.

van der Leest

RJT.

Dowlatshahi

EA.

Hofman

de Vries

Nijsten

. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol. 2013;133(8):1971-1978.doi:10.1038/jid.2013.134

23510990

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.08 MB